Efficacy and Safety of Roxadustat in Chinese Hemodialysis Patients: A Systematic Review and Meta-Analysis

被引：5
作者：
Liang, Qichen [1 ]
Li, Xu [1 ]
Niu, Qingyu [1 ]
Zhao, Huiping [1 ]
Zuo, Li [1 ]
机构：
[1] Peking Univ Peoples Hosp, Dept Nephrol, Beijing 100044, Peoples R China
来源：
JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 07期
基金：
中国国家自然科学基金;
关键词：
roxadustat; hemodialysis; anemia; meta-analysis; systematic review; PROLYL HYDROXYLASE INHIBITORS; KIDNEY-DISEASE; REGULATES HEPCIDIN; ANEMIA; FG-4592; MICE; DEFICIENCY;
D O I：
10.3390/jcm12072450
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
(1) Background: Recently more and more Chinese clinical studies have been conducted to compare the efficacy and safety of roxadustat with erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. We aimed to assess the efficacy and safety of roxadustat in Chinese HD patients. (2) Methods: The PubMed, Embase, the Cochrane Library, Web of Science, WanFang, China National Knowledge Infrastructure (CNKI), SinoMed, and VIP databases were searched from their inception to July 2022 for randomized controlled trials (RCTs) that compared the efficacy and safety of roxadustat to those of ESAs in treating anemia in Chinese HD patients. (3) Results: Twenty-one RCTs involving 1408 patients were enrolled. Our study showed that the improvement of hemoglobin (Hb) levels and iron metabolism were significantly higher in the roxadustat group than in the ESA group. Additionally, the total adverse events risk was significantly lower in the roxadustat group. (4) Conclusions: In this meta-analysis, we found that roxadustat was more effective and safer than ESAs in treating anemia in Chinese HD patients.
引用
收藏
页数：13
相关论文
共 62 条
[1]   The efficacy of Roxadustat for the treatment of anemia in dialysis dependent chronic kidney disease patients: an updated systematic review and meta-analysis of randomized clinical trials [J].
Abdelazeem, Basel ;
Abbas, Kirellos Said ;
Shehata, Joseph ;
El-Shahat, Nahla Ahmed ;
Baral, Nischit ;
Savarapu, Pramod ;
Kunadi, Arvind .
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (23)
[2]  
[Anonymous], 2012, Kidney Int Suppl, V2, P279, DOI [DOI 10.1038/KISUP.2012.37, 10.1038/kisup.2012.37]
[3]   Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients [J].
Besarab, Anatole ;
Chernyayskaya, Elena ;
Motylev, Igor ;
Shutov, Evgeny ;
Kumbar, Lalathaksha M. ;
Gurevich, Konstantin ;
Chan, Daniel Tak Mao ;
Leong, Robert ;
Poole, Lona ;
Zhong, Ming ;
Saikali, Khalil G. ;
Franco, Marietta ;
Hemmerich, Stefan ;
Kin-Hung Peony Yu ;
Neff, Thomas B. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (04) :1225-1233
[4]   Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients [J].
Besarab, Anatole ;
Provenzano, Robert ;
Hertel, Joachim ;
Zabaneh, Raja ;
Klaus, Stephen J. ;
Lee, Tyson ;
Leong, Robert ;
Hemmerich, Stefan ;
Yu, Kin-Hung Peony ;
Neff, Thomas B. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (10) :1665-1673
[5]  
Cao B., 2022, Chin. J. Clin. Ration. Drug Use, V15, P117
[6]  
Charles MVP, 2015, PHARMACOGN RES, V7, P69, DOI [10.4103/0974-8490.150528, 10.4103/0973-7847.156333]
[7]   Long-term efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta-analysis including 13,146 patients [J].
Chen, Huanhuan ;
Cheng, Qingfeng ;
Wang, Jiuxiang ;
Zhao, Xiaofang ;
Zhu, Shenyin .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (04) :999-1009
[8]   Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis [J].
Chen, N. ;
Hao, C. ;
Peng, X. ;
Lin, H. ;
Yin, A. ;
Hao, L. ;
Tao, Y. ;
Liang, X. ;
Liu, Z. ;
Xing, C. ;
Chen, J. ;
Luo, L. ;
Zuo, L. ;
Liao, Y. ;
Liu, B-C ;
Leong, R. ;
Wang, C. ;
Liu, C. ;
Neff, T. ;
Szczech, L. ;
Yu, K-H P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (11) :1001-1010
[9]   Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis [J].
Chen, N. ;
Hao, C. ;
Liu, B-C ;
Lin, H. ;
Wang, Caili ;
Xing, C. ;
Liang, X. ;
Jiang, G. ;
Liu, Zhengrong ;
Li, X. ;
Zuo, L. ;
Luo, L. ;
Wang, J. ;
Zhao, M. ;
Liu, Zhihong ;
Cai, G-Y ;
Hao, L. ;
Leong, R. ;
Wang, Chunrong ;
Liu, C. ;
Neff, T. ;
Szczech, L. ;
Yu, K-H P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (11) :1011-1022
[10]  
Chen N., 2022, China Foreign Med. Treat, V41, P18
1234567